GlassScriptPhysician profile
Seema Dixit
NPI 1144476417
$81,398.83
in general payments reported to CMS, 2019-2025
80 companies · $13K in 2025
The $13K reported for 2025 was more than what 91% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,697 · 2020: $7,146 · 2021: $21K · 2022: $13K · 2023: $9,913 · 2024: $8,302 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,000 · Honoraria: $8,800 · Education: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,392.44 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,000.00 |
| Honoraria | $8,800.00 |
| Education | $211.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $30,104.27 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Axsome Therapeutics, INC. | $9,210.57 | 2023-2025 | Symbravo, Sunosi |
| Allergan, INC. | $8,971.98 | 2019-2021 | |
| Ucb, INC. | $8,591.67 | 2019-2025 | Briviact, Fintepla, Nayzilam |
| Novartis Pharmaceuticals Corporation | $3,264.27 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $2,132.47 | 2019-2021 | |
| Biogen, INC. | $1,770.27 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Teva Pharmaceuticals USA, INC. | $1,536.26 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Lilly USA, LLC | $1,216.57 | 2019-2025 | Emgality, Reyvow, Amyvid |
| Eisai INC. | $1,038.96 | 2019-2025 | |
| Biohaven Pharmaceuticals, INC. | $915.23 | 2021 | |
| Emd Serono, INC. | $835.58 | 2019-2025 | Mavenclad |
| Sk Life Science, INC. | $823.09 | 2020-2025 | |
| Argenx US, INC. | $752.86 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Celgene Corporation | $572.96 | 2021-2025 | Zeposia |
Show all 80 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $507.39 | 2021-2025 | Valtoco |
| Sunovion Pharmaceuticals INC. | $491.45 | 2019-2022 | |
| Amgen INC. | $484.79 | 2019-2025 | Uplizna, Aimovig |
| Alexion Pharmaceuticals, INC. | $468.94 | 2019-2025 | Ultomiris |
| Lundbeck LLC | $466.45 | 2019-2025 | Vyepti, Rexulti |
| Pfizer INC. | $410.52 | 2021-2025 | |
| Kyowa Kirin, INC. | $410.46 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $400.15 | 2019-2025 | Ingrezza, Ongentys |
| Biohaven Pharmaceutical Holding Company LTD. | $386.30 | 2022 | |
| Genentech USA, INC. | $355.78 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Amneal Pharmaceuticals LLC | $329.06 | 2019-2025 | Crexont, Rytary |
| Scilex Pharmaceuticals INC. | $317.62 | 2022-2025 | Ztlido, Elyxyb |
| Impel Pharmaceuticals INC. | $314.28 | 2022-2023 | Trudhesa |
| Janssen Pharmaceuticals, INC | $297.82 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $260.78 | 2023-2024 | Aptiom |
| Acadia Pharmaceuticals INC | $259.28 | 2019-2025 | Nuplazid |
| Genzyme Corporation | $239.17 | 2019-2022 | |
| Idorsia Pharmaceuticals US INC | $234.24 | 2022-2024 | Quviviq |
| Livanova USA, INC. | $179.39 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Csl Behring | $176.35 | 2019-2025 | Hizentra |
| Jazz Pharmaceuticals INC. | $165.01 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $162.86 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $161.55 | 2023-2024 | Rexulti, Nuedexta |
| Upsher-Smith Laboratories LLC | $160.74 | 2020-2023 | |
| Grifols USA, LLC | $103.56 | 2019-2025 | Gamunex-C |
| Bausch Health US, LLC | $102.38 | 2021-2023 | Wellbutrin, Aplenzin |
| Boston Scientific Corporation | $98.00 | 2019-2022 | |
| Aquestive Therapeutics, INC. | $96.89 | 2019-2022 | |
| Aucta Pharmaceuticals, INC. | $94.76 | 2024-2025 | Motpoly Xr |
| Merz Pharmaceuticals, LLC | $93.11 | 2025 | Xeomin, Inbrija, Ampyra |
| Arbor Pharmaceuticals, INC. | $87.71 | 2020-2021 | |
| Greenwich Biosciences, INC. | $82.22 | 2019-2021 | |
| Abbott Laboratories | $76.97 | 2023-2025 | Amplatzer Amulet, Jot Dx |
| Aprecia Pharmaceuticals, LLC | $69.04 | 2019-2023 | Spritam |
| Assertio Therapeutics, INC. | $68.67 | 2019-2020 | |
| Avion Pharmaceuticals | $66.21 | 2022-2023 | Dhivy |
| Medtronic, INC. | $63.47 | 2024-2025 | Inceptiv, Intellis Adaptivestim |
| Corium, LLC | $63.27 | 2022-2023 | Adlarity |
| Octapharma USA, INC. | $61.43 | 2022-2024 | Panzyga |
| Acorda Therapeutics, INC | $58.76 | 2019-2023 | Inbrija, Ampyra |
| Mallinckrodt Hospital Products INC. | $56.75 | 2020-2023 | Acthar |
| Almatica Pharma LLC | $55.45 | 2021-2023 | Gralise |
| Merck Sharp & Dohme LLC | $52.05 | 2020-2023 | Belsomra |
| Vanda Pharmaceuticals INC. | $49.03 | 2025 | Ponvory |
| Merz North America, INC. | $48.89 | 2019-2020 | |
| Adamas Pharmaceuticals, INC. | $48.58 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $44.39 | 2019-2025 | Onpattro |
| Avanir Pharmaceuticals, INC. | $42.21 | 2019 | |
| Tonix Medicines, INC. | $30.69 | 2025 | Zembrace Symtouch |
| Amylyx Pharmaceuticals, INC. | $29.66 | 2023 | Relyvrio |
| Horizon Therapeutics Plc | $29.35 | 2021 | |
| Catalyst Pharmaceuticals, INC. | $24.14 | 2024 | |
| Inspire Medical Systems, INC. | $23.12 | 2025 | Inspire |
| Neuropace, INC. | $22.62 | 2022 | |
| Cala Health, INC. | $20.66 | 2022 | |
| Akcea Therapeutics, INC. | $20.51 | 2019 | |
| Medtronic USA, INC. | $18.18 | 2019 | |
| Azurity Pharmaceuticals, INC. | $17.59 | 2024 | Horizant |
| Mallinckrodt Enterprises LLC | $16.14 | 2019 | |
| Banner Life Sciences, LLC | $15.45 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.98 | 2019 | |
| Promius Pharma LLC | $14.96 | 2019 | |
| Collegium Pharmaceutical, INC. | $14.18 | 2022 | |
| Neuronetics, INC. | $13.62 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seema Dixit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.